Your browser doesn't support javascript.
loading
Fibrotic Cystic Lung Disease Post Hematopoietic Stem Cell Transplant: Who is the Culprit?
Alam, Walid; Mohamad, Rayan; Koubaissi, Maysoun; Koubaissi, Salwa A.
Afiliación
  • Alam W; Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Mohamad R; Pulmonary and Critical Care Division, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Koubaissi M; Department of Internal Medicine, Lebanese University, Beirut, Lebanon.
  • Koubaissi SA; Pulmonary and Critical Care Division, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Clin Med Insights Case Rep ; 15: 11795476221097317, 2022.
Article en En | MEDLINE | ID: mdl-35591973
Pulmonary complications post hematopoietic stem cell transplant (HSCT) are associated with poor outcomes and require extensive management depending on the etiology. They usually present in the form of bronchiolitis obliterans syndrome, interstitial pneumonitis, or drug toxicity that can lead to fibrosis. Scant data exists regarding diffuse cystic lung disease following HSCT, and the existing literature only mentions mild cystic changes. We present the case of a 25-year-old man with stage IVB Hodgkin's lymphoma post allogeneic HSCT, who developed progressive traction bronchiectasis, with the appearance of extensive pulmonary cysts that followed significant fibrotic changes and discuss the possible etiologies behind it.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Med Insights Case Rep Año: 2022 Tipo del documento: Article País de afiliación: Líbano Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Med Insights Case Rep Año: 2022 Tipo del documento: Article País de afiliación: Líbano Pais de publicación: Estados Unidos